Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,566.00    -24.00 (-0.52%)
Bid:
4,592.00
Ask:
4,596.00
Spread: 4.00 (0.087%)
Market Cap: £16.64b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

4 Jan 2022 09:54

RNS Number : 3425X
Coca-Cola HBC AG
04 January 2022
 

FOR IMMEDIATE RELEASE

04 January 2022

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that the deferred bonus award over shares of CHF 6.70 in the Company (the "Deferred Shares") granted under the Company's Management Incentive Plan to Zoran Bogdanovic, Chief Executive Officer, relating to a performance related annual bonus for 2018 vested on 31 December 2021. Following vesting, the PDMR sold sufficient Deferred Shares to cover his tax and other liabilities and the balance of the Deferred Shares was retained.

 PDMR

Number of shares granted under the Deferred Shares vesting

Number of shares sold to cover taxes and other liabilities

Number of shares retained

Zoran Bogdanovic, Chief Executive Officer

7,717

450

7,267

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

VESTING OF DEFERRED SHARES GRANTED IN MARCH 2019 UNDER THE COMPANY'S MANAGEMENT INCENTIVE PLAN

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

7,717

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

7,717

196,551.99 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE DEFERRED SHARES

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

450

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

450

11,461.50 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

 

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKQBPCBKKBDK
Date   Source Headline
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSNotice of EGM
24th Nov 20252:15 pmRNSDirector/PDMR Shareholding
18th Nov 20254:10 pmRNSDirector/PDMR Shareholding
5th Nov 20251:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20259:30 amRNSBlock listing Interim Review
30th Oct 20253:00 pmRNSHolding(s) in Company
23rd Oct 20252:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20252:00 pmRNSDirector/PDMR Shareholding
21st Oct 20257:03 amRNSSolid Q3 performance; guidance reiterated
21st Oct 20257:00 amRNSCCH to acquire Coca-Cola Beverages Africa
20th Oct 20253:45 pmRNSDirector/PDMR Shareholding
30th Sep 202511:30 amRNSNotice of Results
18th Sep 20252:30 pmRNSDirector/PDMR Shareholding
19th Aug 202512:00 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSConsistent execution delivers strong H1 results
4th Aug 20254:45 pmRNSRevolving Credit Facility
18th Jul 202512:15 pmRNSDirector/PDMR Shareholding
15th Jul 20251:00 pmRNSBitesize Investor Series – Nigeria
7th Jul 20251:09 pmRNSNotice of Results
3rd Jul 202510:04 amRNSHolding(s) in Company
2nd Jul 20253:29 pmRNSHolding(s) in Company
30th Jun 20253:32 pmRNSDirector/PDMR Shareholding
30th Jun 20251:44 pmRNSHolding(s) in Company
18th Jun 20252:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:19 pmRNSDirector/PDMR Shareholding
2nd Jun 20258:07 amRNSTransfer of treasury shares & total voting rights
23rd May 20252:05 pmRNSComposition of the Board Committees
23rd May 20251:55 pmRNSResult of AGM and dividend dates
20th May 20252:37 pmRNSDirector/PDMR Shareholding
19th May 202512:22 pmRNSDirector/PDMR Shareholding
7th May 20252:33 pmRNSDirector/PDMR Shareholding
1st May 20259:37 amRNSBlock listing Interim Review
1st May 20259:23 amRNSTransfer of treasury shares & total voting rights
30th Apr 20257:00 amRNSStrong start; reiterating 2025 guidance
23rd Apr 20251:38 pmRNSAGM Notice,changes to BoD,dividend dates-Amendment
23rd Apr 20257:00 amRNSNotice of AGM, changes to the BoD, dividend dates
22nd Apr 202512:42 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:13 amRNSNotice of Results
1st Apr 20259:23 amRNSTransfer of treasury shares & total voting rights
28th Mar 20252:43 pmRNSDirector/PDMR Shareholding
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding
19th Mar 20254:47 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20254:43 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20251:40 pmRNSDirector/PDMR Shareholding
19th Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20251:30 pmRNSDirector/PDMR Shareholding
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.